Genprex (GNPX) Other financing activities (2016 - 2019)

Genprex (GNPX) posted quarterly Other financing activities of $1950.0 for Q1 2019, up 141.72% quarter-over-quarter from -$4674.0 in Q3 2018.

Genprex (GNPX) Other financing activities (2016 - 2019) Analysis & Trends

Genprex's Other financing activities history runs 3 years deep, the most recent figure standing at $1950.0 for Q1 2019.

In Q1 2019, Other financing activities changed N/A year-over-year to $1950.0; the TTM figure through Jun 2019 stood at -$2724.0 (up 74.99% YoY), while the FY2018 annual figure was -$18085.0, changed N/A from the prior year.
Other financing activities for Q1 2019 stood at $1950.0, up from -$4674.0 in the prior quarter.
The five-year high for Other financing activities was $2519.0 in Q4 2016, with the low at -$13411.0 in Q2 2018.
The 3-year median for Other financing activities is -$1362.0 (2018), against an average of -$3404.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Genprex	1.88 Mn	-13.28 Mn	-

Download Data